Fixed-Dose Combination of Dapagliflozin + Sitagliptin + Metformin in Patients with Type 2 Diabetes Poorly Controlled with Metformin: Phase 3, Randomized Comparison with Dual Combinations
Rakesh Sahay, Richa Giri, Jayashree Shembalkar, Sandeep K. Gupta, Brij Mohan, Prakash Kurmi, Sravan Kumar, Vinayak Sawardekar, Ashutosh Mishra, L. Sreenivasa Murthy, Vivek V. Arya, Abhijit R. Sonawane, Pravin Soni, Sandip Gofne, S. Karnawat, Mandodari Rajurkar, Piyush M. Patel, Lalit Lakhwani, Suyog C. Mehta, Sadhna J. Joglekar
Topics & Concepts
MetforminMedicineDapagliflozinSitagliptinType 2 diabetesInternal medicineClinical endpointGlycated hemoglobinRandomized controlled trialPharmacologyGastroenterologyDiabetes mellitusEndocrinologyUrologyInsulinDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerDiabetes Management and Research